Daniyan AF - Search Results

1

BCMA-Targeted CAR T-cell Therapy plus Radiotherapy for the Treatment of Refractory Myeloma Reveals Potential Synergy.

Smith EL, Mailankody S, Staehr M, Wang X, Senechal B, Purdon TJ, Daniyan AF, Geyer MB, Goldberg AD, Mead E, Santomasso BD, Landa J, Rimner A, Riviere I, Landgren O, Brentjens RJ. Smith EL, et al. Among authors: daniyan af. Cancer Immunol Res. 2019 Jul;7(7):1047-1053. doi: 10.1158/2326-6066.CIR-18-0551. Epub 2019 May 21. Cancer Immunol Res. 2019. PMID: 31113804 Free PMC article.

2

At the Bench: Chimeric antigen receptor (CAR) T cell therapy for the treatment of B cell malignancies.

Daniyan AF, Brentjens RJ. Daniyan AF, et al. J Leukoc Biol. 2016 Dec;100(6):1255-1264. doi: 10.1189/jlb.5BT1215-556RR. Epub 2016 Oct 27. J Leukoc Biol. 2016. PMID: 27789538 Free PMC article. Review.

3

Optimized T-cell receptor-mimic chimeric antigen receptor T cells directed toward the intracellular Wilms Tumor 1 antigen.

Rafiq S, Purdon TJ, Daniyan AF, Koneru M, Dao T, Liu C, Scheinberg DA, Brentjens RJ. Rafiq S, et al. Among authors: daniyan af. Leukemia. 2017 Aug;31(8):1788-1797. doi: 10.1038/leu.2016.373. Epub 2016 Dec 7. Leukemia. 2017. PMID: 27924074 Free PMC article.

4

Immunotherapy: Hiding in plain sight: immune escape in the era of targeted T-cell-based immunotherapies.

Daniyan AF, Brentjens RJ. Daniyan AF, et al. Nat Rev Clin Oncol. 2017 Jun;14(6):333-334. doi: 10.1038/nrclinonc.2017.49. Epub 2017 Apr 11. Nat Rev Clin Oncol. 2017. PMID: 28397826 Free PMC article. Review.

5

Engineered Tumor-Targeted T Cells Mediate Enhanced Anti-Tumor Efficacy Both Directly and through Activation of the Endogenous Immune System.

Avanzi MP, Yeku O, Li X, Wijewarnasuriya DP, van Leeuwen DG, Cheung K, Park H, Purdon TJ, Daniyan AF, Spitzer MH, Brentjens RJ. Avanzi MP, et al. Among authors: daniyan af. Cell Rep. 2018 May 15;23(7):2130-2141. doi: 10.1016/j.celrep.2018.04.051. Cell Rep. 2018. PMID: 29768210 Free PMC article.

6

CARs of the future.

Daniyan AF, Brentjens RJ. Daniyan AF, et al. Am J Hematol. 2019 May;94(S1):S55-S58. doi: 10.1002/ajh.25416. Epub 2019 Feb 25. Am J Hematol. 2019. PMID: 30680777 Free PMC article. Review.

7

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.

Kuhn NF, Purdon TJ, van Leeuwen DG, Lopez AV, Curran KJ, Daniyan AF, Brentjens RJ. Kuhn NF, et al. Among authors: daniyan af. Cancer Cell. 2019 Mar 18;35(3):473-488.e6. doi: 10.1016/j.ccell.2019.02.006. Cancer Cell. 2019. PMID: 30889381 Free PMC article.

8

Granulocyte-colony stimulating factor in COVID-19: Is it stimulating more than just the bone marrow?

Nawar T, Morjaria S, Kaltsas A, Patel D, Perez-Johnston R, Daniyan AF, Mailankody S, Parameswaran R. Nawar T, et al. Among authors: daniyan af. Am J Hematol. 2020 Aug;95(8):E210-E213. doi: 10.1002/ajh.25870. Epub 2020 Jul 1. Am J Hematol. 2020. PMID: 32419212 Free PMC article. No abstract available.

9

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response.

Li X, Daniyan AF, Lopez AV, Purdon TJ, Brentjens RJ. Li X, et al. Among authors: daniyan af. Leukemia. 2021 Feb;35(2):506-521. doi: 10.1038/s41375-020-0874-1. Epub 2020 May 23. Leukemia. 2021. PMID: 32447345 Free PMC article.

10

CD103⁺ cDC1 and endogenous CD8⁺ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.

Kuhn NF, Lopez AV, Li X, Cai W, Daniyan AF, Brentjens RJ. Kuhn NF, et al. Among authors: daniyan af. Nat Commun. 2020 Dec 2;11(1):6171. doi: 10.1038/s41467-020-19833-3. Nat Commun. 2020. PMID: 33268774 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters